Brukinsa

View On IPO.GOV.UK

Registered

on 20 Mar 2019

Last Applicant/ Owned by

BeiGene, Ltd.

c/o Mourant Ozannes Corporate Services, 94 Solaris Ave, Camana Bay

Grand Cayman, , KY1-1108

Serial Number

UK00003384915 filed on 20^th Mar 2019

Registration Number

UK00003384915 registered on
7^th Jun 2019

Correspondent Information

Forresters IP LLP

The Gherkin (11th Floor), 30 St Mary Axe

London,

EC3A 8BF

Brukinsa

pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases.

Classification Information

Pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases.

UK00003384915

Figurative

Individual